Загрузка...

Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis

Introduction: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Evidence suggests that MS should be treated as early as possible in order to maximize the benefit of treatment. Areas covered: This review details current understanding about the treatment of relapsing–remitti...

Полное описание

Сохранить в:
Библиографические подробности
Главный автор: Freedman, Mark S
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2014
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4133962/
https://ncbi.nlm.nih.gov/pubmed/24965353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2014.924496
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!